News

AZN

American Journal of Hematology Publishes Positive Data on Rigel's Immune Thrombocytopenia Drug

Edward Kim | Equities.com |

Rigel's Tavalisse, approved 2 weeks ago, showed "clinically‐meaningful responses in ITP patients."


Corvidia Therapeutics Closes $60 Million Series B Round Led by Venrock

Edward Kim | Equities.com |

Using precision genomics to develop cardiovascular and cardio-renal therapies.


Abpro Files for $60 Million IPO to Develop Antibody Therapeutics for Cancer and Vascular Eye Diseases

Edward Kim | Equities.com |

Initial targets are HER2+ solid tumors and diabetic macular edema.


AstraZeneca Gets FDA Approval for Bydureon to be Used with Basal Insulin for Type 2 Diabetes

Edward Kim | Equities.com |

Study results showed significant HbA1c reduction when Bydureon was added to insulin glargine therapy


​Healthy Bets in Oncology: Bristol-Myers Squibb and AstraZeneca

MoneyShow | Equities.com |

Two leading players in the pharmaceutical sector present opportunities in the space of oncology.


Viela Bio Spins Out of MedImmune with $250 Million and Six Developmental Molecules

Edward Kim | Equities.com |

New company to target critical pathways that are root causes of severe autoimmune diseases.


​While Distracted By Lynparza, Markets Missed This AstraZeneca PLC (AZN) Development

Mark Collins | Equities.com |

Here's a look at some secondary but still important news from AZN today.


​Here's What the AstraZeneca and NewLink Genetics Deal Means for Everyone Involved

Mark Collins | Equities.com |

Here's a look at the latest deal in oncology with a look at the science and what it means for the players involved.


Tax Reform Uncertainty Dampening Biotech M&A

Edward Kim | Equities.com |

Lowest level of biotech M&A activity in 4 years.


Inovio Pharmaceuticals (INO): Moving to Phase 3 with First Potential Treatment for HPV Infection of the Cervix

Spotlight Companies | Equities.com |

Inovio Pharmaceuticals is developing the first potential treatment for HPV infection of the cervix and the first non-surgical treatment for pre-cancerous cervical lesions.


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

Blockchain in Digital Identity - Discussion at the EU Parliament

From the recent Blockchain For Europe Summit in Brussels: Panel on Digital Identity